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407-3 Estrogen Augments Incorporation of Bone Marrow- 
Derived Endothelial Progenitor Cells Into Sites of 
Myocardial Neovascularization 
Atsushi Iwakura. Corinne Luedemann, Atsuhiko Kawamoto, Shubha Shastry, Takayuki 
Asahara, Douglas W. Losordo, St. Elizabeth’s Medical Center, Boston, MA 
Background: We hypothesized that estrogen augments incorporation of bone marrw 
(EM)-derived endothelial progenitor cells (EPCs) into sites of neovascularization after 
myocardial infarction (Ml). Methods and Results: Ml was induced by ligation of left core- 
nary artery in 67 ovariectomized FVB mice receiving either 178.estradiol or placebo. Left 
ventricular (LV) function within 2 weeks after MI, assessed by echocardiography and 
catheter tipped manometer, was similar between the groups. However, LV systolic and 
diastolic dimensions and fractional shortening in the estrogen group were preserved 3 
and 4 weeks after Ml as compared to placebo. LV +dPldt and -dP/dt 4 weeks after Ml I” 
the estrogen group were also higher than placebo Capillary density 4 weeks after MI 
was significantly greater in estrogen group (P<O.Ol) Furthermore, ratio of fibrosis area to 
LV area in the estrogen group was significantly lower than placebo (P<O.O5). In cultured 
EPC assay, significant increases in circulating EPCs 2 and 3 weeks after Ml were 
observed I” the estrogen group as compared to placebo (2 wks, 3 wks: PcO.01) To eval- 
uate the effects of estrogen on BM-derived EPCs at the sites of myocardial neovascular- 
ization, we made Ml models using 21 ovariectomized FVB mice transplanted with BM 
from transgenic donors expressing O-galactosidase transcriptionally regulated by endot- 
helial cell-specific Tie-2 promoter. More X-gal positive cells were observed at ischemic 
sites in the estrogen group 1 and 4 weeks after Ml as compared to placebo (Iwk: PcO.05, 
4 wks: PcO.01). Fluorescent immnohistochemistry 1 week after MI documented a 
marked increase I” cells that were double positive for B-gal and endothelial cell-specific 
marker tsolectin 84 in the estrogen group. By using immunohistochemistry and western 
blotting, VEGF expression in the estrogen group was increased both in the infarcted and 
non-infarcted areas 1 week after MI, although eNOS expression was similar between the 
groups. 
Conclusions: Estrogen attenuates LV remodeling and preserves LV function after Ml by 
augmenting incorporation of BM-derived EPCs into sites of myocardial neovasculariza- 
tion that might partially be mediated by VEGF. 
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407-l Reduction of No-Reflow and Infarct Size by lntraaortic 
Balloon Counterpulsation in a Randomized Magnetic 
Resonance Imaging Experimental Study 
Luciano Amado, Dara L. Kraitchman, Bernhard Gerber, Em&o Castlllo, Raymond C. 
Boston, Joseph Grayzel, Joao A. C. Lima, Johns Hopkins University, Baltimore, MD . 
Background: Presence of microvascular obstruction or “no reflow” (NR) within reperiused 
infarcts has been shown to negatively influence left ventricular (LV) remodeling after 
acute myocardlal Infarction (Ml) Intra-aortic balloon counterpulsation (IABC) can 
improve climcal outcomes post-MI but the mechanisms of such effect remain unclear. 
We hypothesized that IABC augmentation ameliorates microvascular obstruction, hence 
reduces the degree of NR. thereby decreasing the final Ml size. 
Methods: Seventeen dogs underwent 90 minutes of closed chest coronary artery occlu- 
sion followed by reperfusion. Animals were randomzed to either IABC (n= 9) or no IABC 
(control, n= 8) after reperfusion. IABC augmentation was performed for the first 24 hours 
post-MI. NR at contrast first- pass and infarct size by delayed-enhancement were mea- 
sured by contrast enhanced (CE) MRI during 24 hours after reperfusion. and compared 
with NR and risk region by microspheres blood flow defined as ~50% of remote flow and 
post-mortem TTC staining. 
Results: Data are presented as percentage of LV mass (Mean&SE). NR decreased sig- 
nificantly in IABC (4.9i2.2; 3.6*1.5 % at 1, and 24 hours, respectively) compared to con- 
trols (3.4+0.5 to 4.8+1.1 % at 1. and 24 hours, respectively; p< 0.01). There was h!gh 
correlation behhreen NR by MRI and microspheres (r= 0.90 and I= 0.83, at lh and 24 
hours, respectwely; p= 0.001) and a good correlation between Ml size by MRI at last time 
point and post-mortem data (r=O.73; p< 0.001). Infarct size by MRI increased with time in 
both groups (from 13.2i1.6 to 15.5i2.1 % at 1 h and 24 hours, respectively; p< 0.05). 
However, Infarct size enlargement at 24 hours in the IABC group (14 % increase) was 
stgnlficantly less than in controls (20 % increase, p< 0.05 between groups). 
Conclusion: IABC performed after reperfusion reduces the extent of NR caused by 
microvascular obstruction in acute Ml. By lmprovlng reperfusion of infarcted myocardium. 
IABC mitigates MI size growth. 
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407-2 Real-Time Magnetic Resonance Imaging for Integrated 
Identification, Targeting, and Injection of Labeled Stem 
Cells to Porcine Myocardial Infarction 
Alexander J. Dick, Michael A. Gunman, Venkatesh K. Raman, Dana C. Peters, Jonathan 
M. Hill, Scott Smith, Greig Scott, Elliot R. McVeigh, Robert J. Lederman, National Heart 
Lung and Blood Institute, Bethesda, MD 
Background: Catheter navigation and myocardial infections have previously been dem- 
onstrated under real-time magnetic rescmance imaging (RT-MRI) guidance. Potential 
applications Include transcatheter injections of therapeutic cell preparations. To be clini- 
cally useful, such technology should combine robust Identification of target pathology, 
device navigation, and cell delivery. We test the feasibility of RT-MRI for both the identifi- 
cation of myocardial infarctions (Ml) and targeted delivery of labeled mesenchymal Stem 
cells (MS&) into infarct borders. 
Methods: Porcine MSCs were dually MRI- and fluorescence-labeled using intracellular 
iron-fluorophore particles (IFPs). In five miwswine, one to seven days pnor to the RT- 
MRI study, Ml was induced by percutaneous coronary artery coil-occlusion. Transfemo- 
ral delivery catheters and Injection needles (Stiletto TM, Boston Scientifc) were modified 
to serve as MRI receiver coils. A 1.5T clinical MRI scanner was customized with rapid 
image reconstruction and Interactive features to enhance interventlonal guidance Con- 
trast between normal and infarcted myocardium was enhanced by intravenous injection 
of O.Pmmol/kg Gd-DTPA resulting in delayed hyperenhancement of the infarct. 
Results: Real-time steady state free-precession imaging with echo-sharing yielded 7 
frames/s of 1.7x3.3x8mm voxels. Catheter naviaation and multiple cell iniections were 
performed wholly under RT-MRI guidance. Targets were selected based on hyperen- 
hancement and wall motion abnormalities of Infarcted tissue. IFP-labeled MSCs were 
readily visualized in viva by MRI as a slgnal void and post-mortem using confocal fluores- 
cence microscopy. 
Conclusion: Targeted delivery of potentially regenerative cellular treatments to infarcted 
myocardium is feasible using multiple catheter coils and RT-MRI visuallzatlon of catheter 
navigation, myocardial function, tissue characteristics, and labeled cells. 
407-4 C-Reactive Protein Directly Attenuates Nitric Oxide 
Release and Bioactivity 
SubodhVerma Shu-Hong Li, Richard D. We&l, Toronto General Hospital, Toronto, ON, 
Canada 
Background: Given the central importance of nltrlc oxide (NO) in the development and 
clinical course of cardiovascular disease?., we sought to determine whether the powerful 
predictive value of C-reactive protein (CRP) might be explained through an effect on NO 
production. 
Methods and Results: Endothelial cells (ECs) were incubated with recombinant CRP (0 
to 100 pg/mL, 24 hours), and NO and cyclic guanoslne monophosphate (cGMP) produc- 
tion was assessed. The effects of CRP on endothelial NO synthase (eNOS) protein, 
mRNA expression, and mRNA stability were also examined. In a separate study, the 
effects of CRP (25 pg/mL) on EC cell survival, apoptosls, and in vitro angiogenesis were 
evaluated. Incubation of ECs with CRP resulted in a significant inhibition of basal and 
stimulated NO release, with concomitant reductions rn CGMPproduction. CRP caused a 
marked downregulation of eNOS mRNA and protein expression. Actinomycin D studies 
suggested that eNOS downregulation was related to decreased mRNA stability. In con- 
IunctIon with a decrease in NO production, CRP inhibited both basal and vascular endot- 
helial growth factor-stimulated angiogenesls as assessed by EC migration and capillary- 
like tube formation. CRP did not induce EC survival but did, however, promote apoptosis 
in a NO-dependent fashion. 
Conclusions: CRP, at concentrations known to predict adverse vascular events, directly 
quenches the production of the NO, in part, through posttranscriptional effect on eNOS 
mRNA stability. DiminIshed NO bioactivity. in turn, inhibits angiogenesis. an important 
compensatory mechanism in chronic ischemia. Through decreasing NO synthesis, CRP 
may facilitate the development of diverse cardiovascular diseases. Risk reduction strate- 
gies designed to lower plasma CRP may be effective by improving NO bioavailability. 
Noon 
407-5 Circulating and Tissue Angiotensin II Type 1 Receptors 
From Perioperation Through One-Year of 
. Transplantation: A Potential Molecular Mechanism for 
Cardiac Allograft Vasculopathy 
Mohammed Yousufuddin, Randall C. Starling, E. Murat Tuzcu, Ashraf Abdo, Philip Paul, 
Showkat Haji. Norman B. Ratliff, Daniel J. Cook, Yasser Saad, Sadashiva Kamik, Patrick 
M. McCarthy, James B. Young, Mohamad H Yamani, Cleveleand Clinic Foundation, 
Cleveland, OH 
The precise molecular mechanism underlying the accelerated progression of cardiac 
allograft vasculopathy (CAV) after transplantation is not known. Objectives and Meth- 
ods: We, therefore, attempted to determine whether angiotensin II (Ang II) receptor type 
1 (AT,) expression, which was assessed by real-time quantitative RT-PCR using Taq- 
Man system (Applied Blosystems, CA) during perioperative period through one year after 
transplantation predicts the development of CAV measured as change in maximal intimal 
thickness (CMIT) and plaque volume (CPV) at worst affected sites by intravascular ultra- 
sound (IVUS). We estimated AT, mRNA expreswn of 1) donor lymphocytes-derived 
